Turning the disruption caused by the ongoing coronavirus (COVID-19) pandemic into an opportunity to venture into new markets, US-headed advanced renewable fuels and biochemicals company Aemetis Inc., has announced the launch of its new Aemetis Health Products subsidiary which is focused on the production and marketing of blended liquid and gel sanitizers as bulk and packaged products.
As a result of the global COVID-19 pandemic, demand for high-grade alcohol for sanitizer production increased significantly in early 2020. Aemetis Health Products will blend gel and liquid sanitizer for delivery in bulk as well as in packaged form to customers.
Aemetis has become the largest producer of high-grade sanitizer alcohol in the western United States and is launching Aemetis Health Products to expand its product line of sanitizer products. This expansion into blended liquid and gel sanitizer markets complements our existing offering of high-grade alcohol in the United States and Canada, said Eric McAfee, Chairman, and CEO of Aemetis
Aemetis is currently constructing plant upgrades of control systems and processing equipment that will enable the production of US Pharmacopeia (USP) medical grade alcohol at the Aemetis plant near Modesto, California (CA).
